Altered mental status (peds): Difference between revisions
ClaireLewis (talk | contribs) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{Peds top}} [[altered mental status]] | |||
==Background== | ==Background== | ||
*Both cerebral cortices must be affected to cause altered mental status | *Both cerebral cortices must be affected to cause altered mental status | ||
*Must quickly determine if [[coma]] or lethargy is from diffuse or focal impairment | |||
==Clinical Features== | ==Clinical Features== | ||
*Depends on cause | |||
**Diffuse brain dysfunction - lack of focal findings | |||
**[[focal neuro deficits|Focal brain dysfunction]] - hemiparesis, loss of motor tone, loss of ocular reflexes | |||
*Important to differentiate diffuse brain dysfunction from localized lesion as a patient may appear confused due to visual deficit, dysphasia, etc. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 49: | Line 54: | ||
|- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | |- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Pericardial tamponade]] | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Pericardial tamponade]] | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | Tumor | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[brain tumor|Tumor]] | ||
|- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | |- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" rowspan="18" | '''E''' | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" rowspan="18" | '''E''' | ||
| Line 57: | Line 62: | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Hypertensive encephalopathy]] | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Hypertensive encephalopathy]] | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" rowspan="16" | '''I''' | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" rowspan="16" | '''I''' | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | Infection | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Infection]] | ||
|- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | |- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Reye syndrome]] | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Reye syndrome]] | ||
| Line 82: | Line 87: | ||
|- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | |- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Addison's disease]] | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Addison's disease]] | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | Arterial thrombosis | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Arterial thrombosis]] | ||
|- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | |- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Congenital adrenal hyperplasia]] | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[Congenital adrenal hyperplasia]] | ||
| Line 103: | Line 108: | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [Na<sup>+</sup>], [Ca<sup>2+</sup>], [Mg<sup>2+</sup>], PO<sub>4</sub><br> | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [Na<sup>+</sup>], [Ca<sup>2+</sup>], [Mg<sup>2+</sup>], PO<sub>4</sub><br> | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" rowspan="2" | '''P''' | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" rowspan="2" | '''P''' | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | Poisoning | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" | [[toxicity|Poisoning]] | ||
|- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | |- class="font12" style="font-size: 12px; margin: 0px 0px 9px; line-height: 17px" | ||
| class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" rowspan="5" | '''I''' | | class="font12" style="font-size: 12px; margin: 0px 0px 9px; color: rgb(51,51,51); line-height: 17px" valign="top" align="left" bgcolor="#ffffff" rowspan="5" | '''I''' | ||
| Line 126: | Line 131: | ||
*[[Salicylates]] | *[[Salicylates]] | ||
*[[Theophylline]] | *[[Theophylline]] | ||
*[[Thyroxine]] | *[[levothyroxine|Thyroxine]] | ||
==Evaluation== | ==Evaluation== | ||
| Line 134: | Line 139: | ||
*Neuroimaging | *Neuroimaging | ||
*XR | *XR | ||
* | *[[UA]] | ||
==Management== | ==Management== | ||
*Immobilize cervical spine for suspected trauma | *Immobilize cervical spine for suspected trauma | ||
*Fluid resuscitation 20 mL/kg x3 as needed; start pressors thereafter | *[[Fluid resuscitation]] 20 mL/kg x3 as needed; start pressors thereafter | ||
*Antibiotics for [[sepsis]] or [[meningitis]] (consider | *[[pediatric antibiotics|Antibiotics]] for [[sepsis]] or [[meningitis]] (consider [[antiviral]] it patient is toxic) | ||
*Naloxone for | *[[Naloxone]] for [[opioid toxicity|opioid]] or [[clonidine toxicity|clonidine overdose]] (0.01-0.1mg/kg IV q2 min) | ||
*Glucose for hypoglycemia (2 mL/kg of 25% dextrose) | *[[dextrose|Glucose]] for [[hypoglycemia (peds)|hypoglycemia]] (2 mL/kg of 25% dextrose) | ||
*Avoid sodium bicarbonate for metabolic acidosis unless pH <7.0 | *''Avoid'' [[sodium bicarbonate]] for [[metabolic acidosis]] unless pH <7.0 | ||
*Control [[seizures]] | *Control [[seizures]] | ||
*Prevent [[hypothermia]], treat hyperthermia | *Prevent [[hypothermia]], treat [[hyperthermia]] | ||
==See Also== | ==See Also== | ||
Latest revision as of 22:48, 28 November 2019
This page is for pediatric patients. For adult patients, see: altered mental status
Background
- Both cerebral cortices must be affected to cause altered mental status
- Must quickly determine if coma or lethargy is from diffuse or focal impairment
Clinical Features
- Depends on cause
- Diffuse brain dysfunction - lack of focal findings
- Focal brain dysfunction - hemiparesis, loss of motor tone, loss of ocular reflexes
- Important to differentiate diffuse brain dysfunction from localized lesion as a patient may appear confused due to visual deficit, dysphasia, etc.
Differential Diagnosis
Additional[1]
- Sympathomimetics/cocaine
- Anticholinergics
- Arsenic
- LSD
- PCP
- Phenothiazines
- Salicylates
- Theophylline
- Thyroxine
Evaluation
- Labs
- Glucose, CBC, chem, UA, CSF, LFT, utox, VBG, BAL, thyroid, Calcium (ionized)
- ECG
- Neuroimaging
- XR
- UA
Management
- Immobilize cervical spine for suspected trauma
- Fluid resuscitation 20 mL/kg x3 as needed; start pressors thereafter
- Antibiotics for sepsis or meningitis (consider antiviral it patient is toxic)
- Naloxone for opioid or clonidine overdose (0.01-0.1mg/kg IV q2 min)
- Glucose for hypoglycemia (2 mL/kg of 25% dextrose)
- Avoid sodium bicarbonate for metabolic acidosis unless pH <7.0
- Control seizures
- Prevent hypothermia, treat hyperthermia
See Also
External Links
References
- ↑ Source APLS page 182, 5th ed.
